Please use this identifier to cite or link to this item: https://doi.org/10.1080/10508422.2016.1189333
DC FieldValue
dc.titleEthical Considerations for Clinical Research and Off-label Use of Ketamine to Treat Mood Disorders: The Balance between Risks and Benefits
dc.contributor.authorMelvyn Zhang
dc.contributor.authorRoger Ho
dc.date.accessioned2018-04-26T08:56:20Z
dc.date.available2018-04-26T08:56:20Z
dc.date.issued2016-06-10
dc.identifier.citationMelvyn Zhang, Roger Ho (2016-06-10). Ethical Considerations for Clinical Research and Off-label Use of Ketamine to Treat Mood Disorders: The Balance between Risks and Benefits. Ethics & Behavior 27 (8) : 681-699. ScholarBank@NUS Repository. https://doi.org/10.1080/10508422.2016.1189333
dc.identifier.issn1050-8422
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/141061
dc.publisherTaylor & Francis
dc.sourceTaylor & Francis
dc.typeArticle
dc.contributor.departmentPSYCHOLOGICAL MEDICINE
dc.description.doi10.1080/10508422.2016.1189333
dc.description.sourcetitleEthics & Behavior
dc.description.volume27
dc.description.issue8
dc.description.page681-699
dc.identifier.isiut000416035100006
Appears in Collections:Staff Publications
Elements

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10.108010508422.2016.1189333.zip91.42 kBZIP

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.